The Committee noted that some Member States (MSs) had a limitation of the use of Diovan after MI to patients intolerant to ACE inhibitors.
Komitee märkis, et mõni liikmesriik oli piiranud Diovani kasutamist müokardiinfarktiga patsientidel vaid nende patsientidega, kes ACE- inhibiitoreid ei talunud.